Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Jun 25 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 3,837 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | RXST | RxSight, Inc. | AGRANT | 37,037 | — | — | +97.8% | Open the original filing on SEC.gov |
| Jun 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 1,928 | $62.94 | $121.3K | -1.8% | Open the original filing on SEC.gov |
| Jun 15 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 10,572 | $61.97 | $655.1K | -8.9% | Open the original filing on SEC.gov |
| Jun 12 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 2,954 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | TARS | Tarsus Pharmaceuticals,… | MEXER | 2,954 | — | — | +2.5% | Open the original filing on SEC.gov |
| Jun 3 | LNSR | LENSAR, Inc. | AGRANT | 17,421 | — | — | +3.2% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 493 | $69.75 | $34.4K | -0.4% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 8,378 | $69.03 | $578.3K | -6.7% | Open the original filing on SEC.gov |
| Mar 16 | TARS | Tarsus Pharmaceuticals,… | SSELL◷ | 3,629 | $68.09 | $247.1K | -2.8% | Open the original filing on SEC.gov |